President Trump's executive order initiates a major shift in U.S. drug policy, potentially moving cannabis to Schedule III. This change could aid medical research and reduce industry taxes. Explore the implications and political divide.
Canadian cannabis stocks experienced a significant rally after former U.S. President Donald Trump signed an executive order to reduce federal restrictions on marijuana. Explore the market impact and what it means for investors.
U.S. President Donald Trump signed an executive order on Dec. 18, 2025, to relax federal marijuana regulations, a move that has ignited optimism within the cannabis industry and could have cross-border implications.
President Trump is expected to sign an executive order reclassifying marijuana, easing federal restrictions on the drug. This major policy shift could have significant implications across North America.
The Biden administration is reviewing a historic shift in U.S. drug policy by reclassifying marijuana, a move with significant implications for Canada's cannabis industry and cross-border relations. Read the latest.
Cannabis hyperemesis syndrome, known as 'scromiting,' is increasing. Learn about this severe condition linked to long-term marijuana use, its symptoms, and the urgent health warning for Canadians.
Federal and provincial governments have collected over $5.4 billion in cannabis tax revenue since legalization. Discover how this revenue is impacting Canadian communities and the economy.
Brazil's agricultural research agency receives approval for cannabis studies in November 2025, marking significant progress in medical marijuana research and agricultural innovation.
Federal budget reveals 10% of Carney's cuts come from reducing marijuana funding for veterans. Veterans Affairs to save $4.23B by reforming cannabis program that supplies 30 tonnes annually.
Massachusetts sheriff reveals jail drug smuggling scheme involving librarian bringing paper infused with synthetic marijuana. Five people indicted in elaborate prison contraband operation.